Xianglong Liu- Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore
Skeletal muscle degeneration manifests through two clinically significant yet mechanistically distinct pathological processes - muscle fatty infiltration (MFI) and fibrosis. These conditions represent major obstacles in the management of age-related muscle wasting, disuse atrophy, and post-traumatic recovery (Cuijpers et al., 2025; Jang and Choi, 2025; Ge et al., 2025; Guo et al., 2025). Intramuscular fat accumulation progressively replaces functional muscle tissue, leading to metabolic dysfunction and weakness, while excessive fibrotic deposition disrupts normal muscle architecture and impairs regenerative capacity (Yu et al., 2025; Farahat et al., 2025). Recent advances in single-cell technologies have begun to unravel the complex cellular dynamics underlying these conditions, revealing unexpected roles for ferroptosis regulation in fibro/adipogenic progenitors (FAPs) during chronic fatty infiltration and macrophage plasticity in acute fibrotic responses, which opens new avenues for targeted interventions in muscle degenerative disorders (Vitaliti et al., 2024; Uapinyoyin et al., 2023).
The study by Sun’ team provides compelling evidence for a previously unrecognized role of ferroptosis suppression in disuse-induced MFI (Tan et al., 2025). Their comprehensive single-cell analysis of immobilized murine muscle uncovered a remarkable subpopulation of FAPs that not only escaped ferroptosis cell death but actively upregulated genes involved in ferroptosis resistance. This finding challenges the conventional view of ferroptosis as a uniformly detrimental process in muscle degeneration. Through elegant in vitro experiments, the researchers demonstrated that pharmacological inhibition of ferroptosis using ferrostatin-1 significantly enhanced the adipogenic potential of both primary FAPs and muscle-derived fibroblasts. These results suggest that the metabolic rewiring of FAPs to resist ferroptosis creates permissive conditions for their pathological differentiation into fat-depositing cells. The study’s clinical relevance is particularly noteworthy, as it identifies ferroptosis modulation as a potential therapeutic strategy to prevent MFI in conditions ranging from sarcopenia to prolonged immobilization.
In contrast to the chronic process of fatty infiltration, acute muscle injury often leads to fibrotic scarring and even bulk lesion, where this team have made groundbreaking discoveries regarding macrophage plasticity. Their work represents the first definitive evidence of macrophage-to-myofibroblast transition (MMT) occurring in skeletal muscle tissue (Qi et al., 2024). By combining sophisticated single-cell transcriptomic approaches with carefully timed in vivo sampling, the researchers captured the dynamic conversion of anti-inflammatory macrophages into collagen-producing myofibroblasts during the critical window of muscle repair. Making a step further, Luo et al. prepared a bioactive hydrogel for regulating macrophage dynamics to promote muscle regeneration after acute trauma (Luo et al., 2025). These findings are particularly exciting as they have unveiled the multifaceted role of macrophages in skeletal muscle regeneration and identified a therapy for skeletal muscle regeneration by inhibiting maladaptive MMT while preserving the beneficial roles of macrophages. This is of particular importance as the promotion of skeletal muscle neogenesis can also serve as a foundation for alleviating muscle atrophy induced by aging or disuse.
The convergence of these serial studies highlights the remarkable plasticity of muscle stromal cells in response to different pathological stimuli. While Tan et al. demonstrate how FAPs adapt their metabolic program to resist ferroptosis and promote fatty degeneration, Qi et al. reveal the unexpected trans-differentiation potential of macrophages in fibrotic scarring. Together, these findings paint a more complete picture of muscle degeneration, where distinct cellular mechanisms dominate different disease phases and contexts. Important questions emerge regarding potential crosstalk between these pathways - could ferroptosis-resistant FAPs create a microenvironment that favors MMT? Might macrophage-derived factors influence the adipogenic potential of resident FAPs? Addressing these questions will be crucial for developing comprehensive treatment strategies that account for the complex cellular interactions in degenerating muscle.
The findings of Sun et al. serve as a basis for tissue engineering in skeletal muscle repair. Previous researches usually focus on the regeneration or hypertrophy of myofiber. However, the formation of multi-nuclei myofiber from mono-nuclei stem cells is a complex process requiring different stimuli in a sequential manner, making it difficult to fabricate appropriate biomaterials. Sun’s team indicates that the fine modulation of stromal cells, including but not limited to FAPs and macrophages, can also be a potential way to regulate skeletal muscle regeneration.
As the understanding of muscle pathophysiology continues to evolve, studies like these that uncover novel cellular behaviors and regulatory mechanisms will be instrumental in developing more effective treatments. The application of advanced single-cell technologies, as demonstrated in both papers, promises to reveal further complexity in muscle degenerative processes and identify additional therapeutic targets. Ultimately, this growing knowledge base should lead to more precise interventions that can maintain muscle quality and function across diverse clinical contexts.
Author contributions
XL: Writing – original draft.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Cuijpers, I., Katsburg, J., van Loon, L. J. C., Troost, F. J., and Sthijns, M. (2025). Nutritional strategies targeting age-related skeletal muscle fibrosis: underlying mechanisms. Crit. Rev. food Sci. Nutr., 1–21. doi:10.1080/10408398.2025.2498676
Farahat, P. K., Kumagai-Cresse, C., Aragón, R. L., Ma, F., Amakor, J. K., Espinoza, A., et al. (2025). Macrophage-derived Spp1 promotes intramuscular fat in dystrophic muscle. JCI insight 10 (13), e181946. doi:10.1172/jci.insight.181946
Ge, X., Jin, Y., He, J., Jia, Z., Liu, Y., and Xu, Y. (2025). Extracellular matrix in skeletal muscle injury and atrophy: mechanisms and therapeutic implications. J. Orthop. Transl. 52, 404–418. doi:10.1016/j.jot.2025.03.004
Guo, X., Zhou, Y., Li, X., and Mu, J. (2025). Resistance exercise training improves disuse-induced skeletal muscle atrophy in humans: a meta-analysis of randomized controlled trials. BMC Musculoskelet. Disord. 26 (1), 134. doi:10.1186/s12891-025-08384-7
Jang, S. Y., and Choi, K. M. (2025). Impact of adipose tissue and lipids on skeletal muscle in sarcopenia. J. cachexia, sarcopenia muscle 16 (4), e70000. doi:10.1002/jcsm.70000
Luo, Z., Wan, R., Qiu, J., Chen, C., Chen, Y., Zhao, Z., et al. (2025). Multi-omics profiling of a self-assembling bioactive hydrogel for immunomodulation and myogenesis in volumetric muscle loss. Chem. 11, 102645. doi:10.1016/j.chempr.2025.102645
Qi, B., Li, Y., Peng, Z., Luo, Z., Zhang, X., Chen, J., et al. (2024). Macrophage-myofibroblast transition as a potential origin for skeletal muscle fibrosis after injury via complement system activation. J. Inflamm. Res. 17, 1083–1094. doi:10.2147/jir.s450599
Tan, J., Li, Y., Zhang, J., Qi, B., Chen, J., and Sun, Y. (2025). Role of aberrant activated fibro/adipogenic progenitors and suppressed ferroptosis in disused skeletal muscle atrophy and fatty infiltration. J. Mol. Med. Berlin, Ger. 103 (6), 713–724. doi:10.1007/s00109-025-02548-7
Uapinyoying, P., Hogarth, M., Battacharya, S., Mázala, D. A. G., Panchapakesan, K., Bönnemann, C. G., et al. (2023). Single-cell transcriptomic analysis of the identity and function of fibro/adipogenic progenitors in healthy and dystrophic muscle. iScience 26 (8), 107479. doi:10.1016/j.isci.2023.107479
Vitaliti, A., Reggio, A., Colletti, M., Galardi, A., and Palma, A. (2024). Integration of single-cell datasets depicts profiles of macrophages and fibro/adipogenic progenitors in dystrophic muscle. Exp. cell Res. 442 (1), 114197. doi:10.1016/j.yexcr.2024.114197
Keywords: skeletal muscle, regeneration, degeneration, biomaterials, stromal cells
Citation: Liu X (2025) Stromal cells unifying the pathology of acute and chronic skeletal muscle injury – clue for novel biomaterials. Front. Bioeng. Biotechnol. 13:1684310. doi: 10.3389/fbioe.2025.1684310
Received: 12 August 2025; Accepted: 08 September 2025;
Published: 03 October 2025.
Edited by:
Yanan Jiang, Harbin Medical University, ChinaReviewed by:
Xiang-Dong Wu, Beijing Jishuitan Hospital, ChinaCopyright © 2025 Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xianglong Liu, eGxsaXVAbnVzLmVkdS5zZw==